title: Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
abstract: OBJECTIVE
  To report the result of intravitreal triamcinolone acetonide in the treatment of sympathetic ophthalmia.
  
  
  METHODS
  A 29-year-old woman who suffered from sympathetic ophthalmia and who was being treated with systemic corticosteroid therapy received an intravitreal injection of 4 mg of triamcinolone acetonide.
  
  
  RESULTS
  By the 15th day after injection visual acuity had improved from 20/200 to 20/40 and serous retinal detachment had almost completely resorbed. Systemic corticosteroid therapy was reduced sequentially. By the third month after injection, the patient was in clinical remission. Her visual acuity was 20/20 and no serous detachment was observed.
  
  
  CONCLUSIONS
  In this study, short-term improvement in the clinical picture of a patient with sympathetic ophthalmia after intravitreal triamcinolone acetonide injection was described. The results suggest that intravitreal triamcinolone acetonide injection may be an additional tool in the treatment of sympathetic ophthalmia.
authors.affiliation: Istanbul Retina Institute Inc., Hakki Yeten Cad., No: 8/7, Sisli 34349 Istanbul, Turkey.
authors.forename: Hakan
authors.initials: H
authors.lastname: Ozdemir
authors.forename: Murat
authors.initials: M
authors.lastname: Karacorlu
authors.forename: Serra
authors.initials: S
authors.lastname: Karacorlu
mesh_terms: D000208:Acute Disease; D000328:Adult; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy*; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide